PHARMCO II ApS — Credit Rating and Financial Key Figures
CVR number: 25202899
Tinglykke 4-6, Skrydstrup 6500 Vojens
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | -47.25 | -50.13 |
EBIT | -47.25 | -50.13 |
Other financial income | 11 094.91 | 4 529.58 |
Other financial expenses | - 860.49 | -1 119.70 |
Net income from associates (fin.) | 4 096.02 | 4 477.98 |
Pre-tax profit | 14 283.20 | 7 837.74 |
Income taxes | -1 312.81 | - 741.11 |
Net earnings | 12 970.39 | 7 096.62 |
Assets (kDKK)
2023 | 2024 | |
---|---|---|
Intangible assets total | ||
Tangible assets total | ||
Holdings in group member companies | 24 299.44 | 28 715.95 |
Investments total | 24 299.44 | 28 715.95 |
Long term receivables total | ||
Inventories total | ||
Current deferred tax assets | 13.97 | 1 569.79 |
Short term receivables total | 13.97 | 1 569.79 |
Other current investments | 81 476.01 | 84 629.64 |
Cash and bank deposits | 3 613.39 | 4 682.62 |
Cash and cash equivalents | 85 089.40 | 89 312.26 |
Balance sheet total (assets) | 109 402.81 | 119 598.00 |
Equity and liabilities (kDKK)
2023 | 2024 | |
---|---|---|
Share capital | 125.00 | 125.00 |
Other reserves | 6 900.25 | 11 316.76 |
Retained earnings | 65 093.13 | 73 585.54 |
Profit of the financial year | 12 970.39 | 7 096.62 |
Shareholders equity total | 85 088.77 | 92 123.91 |
Non-current liabilities total | ||
Current trade creditors | 15.00 | 15.00 |
Current owed to group member | 9 443.75 | 12 578.65 |
Short-term deferred tax liabilities | 614.06 | 21.78 |
Other non-interest bearing current liabilities | 14 241.23 | 14 858.66 |
Current liabilities total | 24 314.04 | 27 474.09 |
Balance sheet total (liabilities) | 109 402.81 | 119 598.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.